@FierceMedDev: Sonitus turns to Europe for the commercial rollout of its new hearing aid. It transmits sound through teeth. Release | Follow @FierceMedDev
@MarkHFierce: Whites are more likely to be treated with CRT-D therapy than blacks and Hispanics, according to a new study. Article | Follow @MarkHFierce
@DamianFierce: Hologic has to fork over $4M after losing a patent suit to Smith & Nephew. News | Follow @DamianFierce
> Medical device companies have been slow to embrace social media compared to other biotechs, with fewer than half the firms surveyed by Frost & Sullivan having any social media presence. Article
> SinuSys got a CE mark for the AerOs sinus dilation system, designed to open the sinus ostia to restore drainage and ventilation. News
> Bloomberg takes a look at the race to develop a bionic eye to help the world's 285 million blindness sufferers. Article
> Vertos Medical is squabbling with a doctor who, after administering a trial for a back pain-treating device, followed up with patients on his own and reported that the tech had failed them. Story
> Devicemaker Nordion reported net income of $12.3 million in its third quarter, a boost over the $4.1 million loss the company took in the same period last year. Item
> Germany's aap Implantate got 510(k) clearance for the small fragment plating line of its Loqteq trauma plating system. Release
> Continuing its campaign to cut back on how much radiation patients are exposed to, GE Healthcare ($GE) has partnered with Advocate Health Care to install its DoseWatch software for CT scans performed by the health system. More
Biotech News
@FierceBiotech: HGS sharpens ax as restructuring claims 114 jobs. Item | Follow @FierceBiotech
@JohnCFierce: Five down (as in 5 straight late-stage failures): Another Eli Lilly drug flunks a Phase III test. Article | Follow @JohnCFierce
> Zymeworks snags $11M, Merck milestone to fuel bi-specific antibody work. More
> Tufts: Cancer drugs win a speedier race to the FDA goal line. Story
> Merck KGaA grabs a cancer antibody hybrid in $625M Symphogen pact. News
Pharma News
@FiercePharma: Jazz Pharma is selling its women's health business to Meda for $95M; 60 jobs to go along--AP. News | Follow @FiercePharma
> Top Warner Chilcott investors to unload 43M shares. Article
> Public Citizen sues FDA over Aricept safety. News
> New Indian price caps would raise another hurdle to Big Pharma. Story
Vaccines News
> University of Oklahoma advances work on West Nile vaccine. Item
> Low HPV vaccination rates spur calls for wider use. Article
> Dendritic cells raise questions about cancer vax effectiveness. More
> ImmusanT launches U.S. trial for celiac vax. News
Pharma Manufacturing News
> Sun recalls biosimilar used for treating brain bleeding. More
> Under regulatory cloud, CEO says Novartis must boost quality. Article
> Competitors' manufacturing screw-ups keep Fresenius busy. Story